GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL

GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL was reported 148 times

GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TARSAL TUNNEL DECOMPRESSION 1 0.0833
1 SCROTAL IRRITATION 1 0.0227
2 PERITONEAL INFECTION 1 0.0122
3 BLOOD ERYTHROPOIETIN INCREASED 1 0.0101
4 ANAL DISCOMFORT 1 0.0065
5 PRIMARY HYPERALDOSTERONISM 1 0.0064
6 COR PULMONALE CHRONIC 1 0.0053
7 MYELOPROLIFERATIVE DISORDER 1 0.0041
8 BONE MARROW RETICULIN FIBROSIS 1 0.0039
9 INJECTION SITE CYST 1 0.0034
10 BACTERIAL TEST 1 0.0034
11 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 1 0.0029
12 SYNOVIAL DISORDER 1 0.0022
13 TYPE V HYPERLIPIDAEMIA 1 0.0021
14 FAECAL VOMITING 1 0.0019
15 ALLERGY TO METALS 1 0.0016
16 PUPILLARY DISORDER 1 0.0016
17 HELLP SYNDROME 1 0.0016
18 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
19 SKIN DEPIGMENTATION 2 0.0015
20 PAINFUL DEFAECATION 1 0.0014
21 ANTIBODY TEST ABNORMAL 1 0.0014
22 HAEMORRHOIDAL HAEMORRHAGE 6 0.0012
23 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
24 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
25 SEIZURE CLUSTER 1 0.0012
26 GENITAL BURNING SENSATION 1 0.0012
27 EYELID RASH 1 0.0010
28 INFUSION SITE DISCOMFORT 1 0.0010
29 ANAL PRURITUS 2 0.0010
30 STREPTOCOCCAL BACTERAEMIA 1 0.0009
31 BACTERIAL TEST POSITIVE 2 0.0009
32 UTERINE DISORDER 2 0.0009
33 NEPHROCALCINOSIS 1 0.0008
34 EYELID SKIN DRYNESS 1 0.0008
35 INFUSION SITE WARMTH 1 0.0008
36 LIP HAEMORRHAGE 1 0.0008
37 INFUSION SITE IRRITATION 1 0.0008
38 INFUSION SITE RASH 1 0.0007
39 ANAL HAEMORRHAGE 2 0.0007
40 NEUTROPHIL COUNT ABNORMAL 2 0.0007
41 INFUSION SITE INDURATION 1 0.0007
42 RUBBER SENSITIVITY 1 0.0007
43 MEGACOLON 1 0.0006
44 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
45 COSTOCHONDRITIS 1 0.0006
46 OROPHARYNGEAL BLISTERING 1 0.0006
47 PATHOLOGICAL GAMBLING 1 0.0006
48 INFUSION SITE DISCHARGE 1 0.0006
49 ANORECTAL DISCOMFORT 3 0.0006
50 HAEMORRHOIDS 11 0.0006
51 ESSENTIAL HYPERTENSION 1 0.0005
52 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
53 CONCOMITANT DISEASE PROGRESSION 1 0.0005
54 ANORECTAL DISORDER 1 0.0005
55 DIABETIC NEPHROPATHY 1 0.0005
56 COLONOSCOPY 1 0.0005
57 BRAIN OPERATION 1 0.0004
58 CYTOMEGALOVIRUS COLITIS 1 0.0004
59 ESCHERICHIA BACTERAEMIA 1 0.0004
60 PRURITUS GENITAL 1 0.0004
61 ORAL INTAKE REDUCED 1 0.0004
62 DEVICE INFUSION ISSUE 1 0.0004
63 CATHETER SITE HAEMORRHAGE 1 0.0004
64 SYSTEMIC CANDIDA 1 0.0004
65 EAR CONGESTION 1 0.0004
66 THYROID NEOPLASM 1 0.0004
67 ESCHERICHIA SEPSIS 1 0.0003
68 DEVICE POWER SOURCE ISSUE 1 0.0003
69 INFUSION SITE REACTION 1 0.0003
70 RECTAL HAEMORRHAGE 14 0.0003
71 RECTAL CANCER 1 0.0003
72 NEPHROPATHY 3 0.0003
73 BLADDER PAIN 1 0.0003
74 PROCTALGIA 2 0.0003
75 BACTERIAL SEPSIS 1 0.0003
76 POLYP 2 0.0003
77 INFUSION SITE HAEMORRHAGE 1 0.0003
78 NEPHRITIS 1 0.0003
79 THERMAL BURN 2 0.0003
80 SKIN WEEPING 1 0.0003
81 RECTAL DISCHARGE 1 0.0003
82 FOREIGN BODY 1 0.0002
83 ACCIDENTAL EXPOSURE 1 0.0002
84 INFUSION SITE ERYTHEMA 2 0.0002
85 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
86 CHAPPED LIPS 1 0.0002
87 HAEMORRHAGIC ANAEMIA 1 0.0002
88 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
89 ARTHRITIS INFECTIVE 1 0.0002
90 MULTIPLE MYELOMA 1 0.0002
91 ENTEROCOCCAL INFECTION 1 0.0002
92 RENAL TUBULAR NECROSIS 2 0.0002
93 PATHOLOGICAL FRACTURE 1 0.0002
94 PETIT MAL EPILEPSY 1 0.0002
95 PERIPHERAL VASCULAR DISORDER 1 0.0002
96 VARICOSE VEIN 1 0.0002
97 INTENTIONAL DRUG MISUSE 4 0.0002
98 SERUM FERRITIN INCREASED 1 0.0002
99 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
100 ERYTHEMA OF EYELID 1 0.0002
101 FAECALOMA 1 0.0002
102 GASTROINTESTINAL PAIN 2 0.0002
103 HAEMORRHAGE 19 0.0002
104 HYPOVOLAEMIA 1 0.0002
105 ENERGY INCREASED 1 0.0002
106 DRUG ABUSER 1 0.0002
107 PRE-EXISTING CONDITION IMPROVED 1 0.0002
108 THERAPEUTIC RESPONSE CHANGED 1 0.0002
109 INFUSION SITE PAIN 2 0.0002
110 POOR QUALITY DRUG ADMINISTERED 1 0.0002
111 HAEMATOCHEZIA 8 0.0001
112 DEFAECATION URGENCY 1 0.0001
113 MAJOR DEPRESSION 1 0.0001
114 MOUTH HAEMORRHAGE 1 0.0001
115 APPLICATION SITE PAIN 3 0.0001
116 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
117 BOWEL MOVEMENT IRREGULARITY 1 0.0001
118 RENAL FAILURE CHRONIC 1 0.0001
119 TRICUSPID VALVE INCOMPETENCE 1 0.0001
120 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
121 RHINITIS 1 0.0001
122 ABNORMAL FAECES 1 0.0001
123 LUNG INFILTRATION 1 0.0001
124 LIP DRY 1 0.0001
125 EXOSTOSIS 1 0.0001
126 FLANK PAIN 1 0.0001
127 INABILITY TO AFFORD MEDICATION 1 0.0001
128 EMPHYSEMA 1 0.0001
129 MOTOR DYSFUNCTION 1 0.0001
130 EAR DISCOMFORT 1 0.0001
131 WEIGHT FLUCTUATION 1 0.0001
132 INJECTION SITE DISCOMFORT 1 0.0001
133 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
134 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
135 RENAL FAILURE ACUTE 4 0.0001
136 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
137 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
138 INTESTINAL PERFORATION 1 0.0001
139 BLOOD CALCIUM DECREASED 1 0.0001
140 HEART RATE IRREGULAR 2 0.0001
141 MITRAL VALVE INCOMPETENCE 1 0.0001
142 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
143 BURNING SENSATION 6 0.0001
144 CHOLECYSTITIS 1 0.0001
145 SCHIZOPHRENIA 1 0.0001
146 TENDON RUPTURE 1 0.0001
147 CYST 1 0.0001
148 APPLICATION SITE IRRITATION 1 0.0001
149 ROTATOR CUFF SYNDROME 1 0.0001
150 HIATUS HERNIA 1 0.0001
151 NODULE 1 0.0001
152 TOOTH INFECTION 1 0.0001
153 DRUG TOXICITY 1 0.0001
154 SEASONAL ALLERGY 1 0.0001
155 DYSSTASIA 2 0.0001
156 SKIN HAEMORRHAGE 1 0.0001
157 PULMONARY MASS 1 0.0001
158 INSURANCE ISSUE 1 0.0001
159 DRUG ADMINISTRATION ERROR 2 0.0001
160 TENDONITIS 1 0.0001
161 THERAPY PARTIAL RESPONDER 1 0.0001
162 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
163 PNEUMOTHORAX 1 0.0001
164 PREMATURE DELIVERY 1 0.0001
165 OBESITY 1 0.0001
166 BLOOD POTASSIUM INCREASED 1 0.0001
167 COAGULOPATHY 1 0.0001
168 MULTI-ORGAN FAILURE 1 0.0001
169 NEUROTOXICITY 1 0.0001
170 METASTASES TO LIVER 1 0.0001
171 GALLBLADDER DISORDER 1 0.0001
172 GOUT 1 0.0001
173 PANIC ATTACK 2 0.0001
174 BLOOD GLUCOSE ABNORMAL 1 0.0001
175 COLITIS 2 0.0001
176 GASTRIC ULCER 1 0.0001
177 PROTEINURIA 1 0.0001
178 POST PROCEDURAL COMPLICATION 1 0.0001
179 ORAL HERPES 1 0.0001
180 PREGNANCY 1 0.0000
181 ABORTION SPONTANEOUS 2 0.0000
182 IRRITABLE BOWEL SYNDROME 1 0.0000
183 POOR QUALITY SLEEP 1 0.0000
184 PRURITUS GENERALISED 1 0.0000
185 CHILLS 5 0.0000
186 BLOOD PRESSURE FLUCTUATION 1 0.0000
187 FIBROMYALGIA 1 0.0000
188 CEREBRAL INFARCTION 1 0.0000
189 DYSGEUSIA 3 0.0000
190 AGGRESSION 2 0.0000
191 DRUG RESISTANCE 1 0.0000
192 INJECTION SITE BRUISING 3 0.0000
193 FREQUENT BOWEL MOVEMENTS 1 0.0000
194 PALLOR 1 0.0000
195 PROCEDURAL PAIN 1 0.0000
196 MENTAL STATUS CHANGES 1 0.0000
197 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
198 RENAL IMPAIRMENT 3 0.0000
199 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
200 PAIN IN JAW 1 0.0000
201 RED BLOOD CELL COUNT DECREASED 1 0.0000
202 GASTROINTESTINAL DISORDER 3 0.0000
203 IRRITABILITY 2 0.0000
204 CORONARY ARTERY DISEASE 1 0.0000
205 STOMATITIS 2 0.0000
206 FEELING HOT 2 0.0000
207 HYPOTHYROIDISM 1 0.0000
208 HIP FRACTURE 1 0.0000
209 STAPHYLOCOCCAL INFECTION 1 0.0000
210 TREMOR 5 0.0000
211 FUNGAL INFECTION 1 0.0000
212 SKIN DISORDER 1 0.0000
213 URINARY RETENTION 1 0.0000
214 DRY SKIN 4 0.0000
215 EYE PRURITUS 1 0.0000
216 TYPE 2 DIABETES MELLITUS 1 0.0000
217 URINARY TRACT INFECTION 5 0.0000
218 HAEMATURIA 1 0.0000
219 DEVICE USE ERROR 1 0.0000
220 HYPOXIA 1 0.0000
221 CONSTIPATION 6 0.0000
222 EYE SWELLING 1 0.0000
223 HEPATIC FUNCTION ABNORMAL 1 0.0000
224 DYSPNOEA EXERTIONAL 1 0.0000
225 INTESTINAL OBSTRUCTION 1 0.0000
226 ANAEMIA 5 0.0000
227 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
228 DECREASED APPETITE 6 0.0000
229 ABNORMAL BEHAVIOUR 1 0.0000
230 INJECTION SITE HAEMORRHAGE 2 0.0000
231 DRY MOUTH 2 0.0000
232 DEVICE BREAKAGE 1 0.0000
233 OSTEOARTHRITIS 1 0.0000
234 DEVICE LEAKAGE 1 0.0000
235 VAGINAL HAEMORRHAGE 1 0.0000
236 MENTAL DISORDER 1 0.0000
237 PSORIASIS 3 0.0000
238 DRUG WITHDRAWAL SYNDROME 2 0.0000
239 LIVER DISORDER 1 0.0000
240 INSOMNIA 6 0.0000
241 DEHYDRATION 3 0.0000
242 THROAT IRRITATION 1 0.0000
243 THERAPY NON-RESPONDER 1 0.0000
244 OROPHARYNGEAL PAIN 2 0.0000
245 BACK PAIN 5 0.0000
246 BLOOD CHOLESTEROL INCREASED 1 0.0000
247 CARDIAC DISORDER 2 0.0000
248 OCULAR HYPERAEMIA 1 0.0000
249 MIGRAINE 2 0.0000
250 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
251 DYSPEPSIA 2 0.0000
252 HEART RATE INCREASED 2 0.0000
253 DRY EYE 1 0.0000
254 CONDITION AGGRAVATED 6 0.0000
255 FLUSHING 2 0.0000
256 FLUID RETENTION 1 0.0000
257 BLOOD PRESSURE INCREASED 3 0.0000
258 ILLNESS 2 0.0000
259 INFLAMMATION 1 0.0000
260 ABDOMINAL DISTENSION 2 0.0000
261 NERVOUSNESS 1 0.0000
262 ECZEMA 1 0.0000
263 SPEECH DISORDER 1 0.0000
264 PANCREATITIS 1 0.0000
265 DEPRESSED MOOD 1 0.0000
266 DRUG INTERACTION 3 0.0000
267 HYPERTENSION 4 0.0000
268 DRUG DEPENDENCE 3 0.0000
269 DIARRHOEA 12 0.0000
270 DRUG EFFECT DECREASED 1 0.0000
271 RASH PRURITIC 1 0.0000
272 OEDEMA 1 0.0000
273 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
274 PANCYTOPENIA 1 0.0000
275 BLISTER 1 0.0000
276 OXYGEN SATURATION DECREASED 1 0.0000
277 CEREBROVASCULAR ACCIDENT 3 0.0000
278 FLATULENCE 1 0.0000
279 HEADACHE 11 0.0000
280 LETHARGY 1 0.0000
281 DYSPHONIA 1 0.0000
282 SURGERY 1 0.0000
283 NASAL CONGESTION 1 0.0000
284 WHEEZING 1 0.0000
285 CATARACT 1 0.0000
286 FATIGUE 13 0.0000
287 THERAPEUTIC RESPONSE DECREASED 1 0.0000
288 SUICIDE ATTEMPT 1 0.0000
289 PLEURAL EFFUSION 1 0.0000
290 PAIN 10 0.0000
291 VISUAL IMPAIRMENT 2 0.0000
292 INTENTIONAL OVERDOSE 1 0.0000
293 RHINORRHOEA 1 0.0000
294 DEEP VEIN THROMBOSIS 1 0.0000
295 SWELLING FACE 1 0.0000
296 DEVICE DIFFICULT TO USE 1 0.0000
297 NEOPLASM MALIGNANT 1 0.0000
298 HYPOTENSION 3 0.0000
299 INJECTION SITE PRURITUS 1 0.0000
300 ERYTHEMA 3 0.0000
301 VISION BLURRED 2 0.0000
302 COUGH 4 0.0000
303 INJURY 1 0.0000
304 SLEEP DISORDER 1 0.0000
305 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
306 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
307 MOBILITY DECREASED 1 0.0000
308 RESPIRATORY FAILURE 1 0.0000
309 AGITATION 1 0.0000
310 DEPRESSION 3 0.0000
311 INJECTION SITE PAIN 4 0.0000
312 PRURITUS 5 0.0000
313 FEELING ABNORMAL 3 0.0000
314 CONFUSIONAL STATE 2 0.0000
315 INFLUENZA LIKE ILLNESS 1 0.0000
316 DRUG INEFFECTIVE 16 0.0000
317 DRUG ABUSE 1 0.0000
318 PYREXIA 4 0.0000
319 RASH 5 0.0000
320 INTENTIONAL PRODUCT MISUSE 1 0.0000
321 MALAISE 5 0.0000
322 TACHYCARDIA 1 0.0000
323 DEVICE ISSUE 1 0.0000
324 SUICIDAL IDEATION 1 0.0000
325 NASOPHARYNGITIS 2 0.0000
326 CHEST PAIN 2 0.0000
327 WEIGHT DECREASED 3 0.0000
328 ASTHENIA 4 0.0000
329 VOMITING 5 0.0000
330 ANXIETY 3 0.0000
331 NAUSEA 8 0.0000
332 DIZZINESS 5 0.0000
333 SOMNOLENCE 2 0.0000
334 HAEMOGLOBIN DECREASED 1 0.0000
335 ABDOMINAL PAIN UPPER 2 0.0000
336 PLATELET COUNT DECREASED 1 0.0000
337 FALL 3 0.0000
338 INFLUENZA 1 0.0000
339 DYSPNOEA 5 0.0000
340 SEIZURE 1 0.0000
341 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
342 ABDOMINAL PAIN 2 0.0000
343 JOINT SWELLING 1 0.0000
344 INJECTION SITE ERYTHEMA 1 0.0000
345 HYPERHIDROSIS 1 0.0000
346 RENAL FAILURE 1 0.0000
347 PRODUCT QUALITY ISSUE 1 0.0000
348 NEUTROPENIA 1 0.0000
349 HYPOAESTHESIA 1 0.0000
350 PARAESTHESIA 1 0.0000
351 URTICARIA 1 0.0000
352 ABDOMINAL DISCOMFORT 1 0.0000
353 MYOCARDIAL INFARCTION 1 0.0000
354 MUSCLE SPASMS 1 0.0000
355 HYPERSENSITIVITY 1 0.0000
356 BLOOD GLUCOSE INCREASED 1 0.0000
357 ALOPECIA 1 0.0000
358 ARTHRALGIA 2 0.0000
359 DEATH 4 0.0000
360 INCORRECT DOSE ADMINISTERED 1 0.0000
361 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
362 PAIN IN EXTREMITY 1 0.0000
363 PNEUMONIA 1 0.0000
364 OFF LABEL USE 2 0.0000